Aethlon Medical (AEMD) reported a Q4 2025 loss of $3.7 per share, compared to an estimated loss of $1.01 per share.
This marks a 307.7% increase in loss compared to the estimated earnings.
The company’s earnings worsened by 306.6% compared to a loss of $0.91 per share in the same quarter last year.
